Cargando…
Acetate decreases PVR/CD155 expression via PI3K/AKT pathway in cancer cells
In recent years, restoring anti-tumor immunity has garnered a growing interest in cancer treatment. As potential therapeutics, immune checkpoint inhibitors have demonstrated benefits in many clinical studies. Although various methods have been applied to suppress immune checkpoints to boost anti-tum...
Autores principales: | Tran, Na Ly, Lee, In Kyu, Choi, Jungkyun, Kim, Sang-Heon, Oh, Seung Ja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411046/ https://www.ncbi.nlm.nih.gov/pubmed/34353426 http://dx.doi.org/10.5483/BMBRep.2021.54.8.060 |
Ejemplares similares
-
PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma
por: Lee, Byung-Hyun, et al.
Publicado: (2022) -
CD155/PVR plays a key role in cell motility during tumor cell invasion and migration
por: Sloan, Kevin E, et al.
Publicado: (2004) -
Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule
por: Bottino, Cristina, et al.
Publicado: (2003) -
Plumbagin induces RPE cell cycle arrest and apoptosis via p38 MARK and PI3K/AKT/mTOR signaling pathways in PVR
por: Chen, Haiting, et al.
Publicado: (2018) -
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation
por: Fionda, Cinzia, et al.
Publicado: (2015)